Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
There is an upward development for Jazz Pharmaceuticals plc compared to yesterday, with an increase of €3.50 (1.600%).
With 41 Buy predictions and not a single Sell prediction Jazz Pharmaceuticals plc is an absolute favorite of our community.
On the other hand, the target price of 222 € is below the current price of 222.7 € for Jazz Pharmaceuticals plc, so the potential is actually -0.31%.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 1.600% | -1.836% | 5.031% | 119.507% | 51.801% | 85.841% | 53.340% |
| Opko Health Inc. | 1.800% | 8.824% | -15.267% | 6.403% | 1.816% | -30.927% | -62.335% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -10.569% | 0.917% | -45.274% | -56.000% |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | 0.580% | 0.585% | 10.968% | -13.131% | -12.245% | -34.351% | -21.818% |
Comments
Jazz Pharmaceuticals (JAZZ) had its price target raised by Needham & Company LLC from $255.00 to $282.00. They now have a "buy" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) was upgraded by Canaccord Genuity Group Inc. to "strong-buy".
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its price target raised by Wells Fargo & Company from $265.00 to $285.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat